167 related articles for article (PubMed ID: 8958390)
1. Ischaemic stroke in infancy and childhood: role of the Arg506 to Gln mutation in the factor V gene.
Nowak-Göttl U; Sträter R; Dübbers A; Oleszuk-Raschke K; Vielhaber H
Blood Coagul Fibrinolysis; 1996 Oct; 7(7):684-8. PubMed ID: 8958390
[TBL] [Abstract][Full Text] [Related]
2. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
De Stefano V; Leone G
Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
[TBL] [Abstract][Full Text] [Related]
3. Activated protein C resistance--a major risk factor for thrombosis.
Rosén SB; Sturk A
Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency.
Zöller B; Holm J; Svensson P; Dahlbäck B
Thromb Haemost; 1996 Feb; 75(2):270-4. PubMed ID: 8815575
[TBL] [Abstract][Full Text] [Related]
5. APC resistance in childhood thromboembolism: diagnosis and clinical aspects.
Nowak-Göttl U; Schneppenheim R; Vielhaber H
Semin Thromb Hemost; 1997; 23(3):253-8. PubMed ID: 9255906
[TBL] [Abstract][Full Text] [Related]
6. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
Zöller B; Svensson PJ; He X; Dahlbäck B
J Clin Invest; 1994 Dec; 94(6):2521-4. PubMed ID: 7989612
[TBL] [Abstract][Full Text] [Related]
7. Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction.
Kontula K; Ylikorkala A; Miettinen H; Vuorio A; Kauppinen-Mäkelin R; Hämäläinen L; Palomäki H; Kaste M
Thromb Haemost; 1995 Apr; 73(4):558-60. PubMed ID: 7495058
[TBL] [Abstract][Full Text] [Related]
8. Stroke in children: inherited and acquired factors and age-related variations in the presentation of 48 paediatric patients.
Del Balzo F; Spalice A; Ruggieri M; Greco F; Properzi E; Iannetti P
Acta Paediatr; 2009 Jul; 98(7):1130-6. PubMed ID: 19432826
[TBL] [Abstract][Full Text] [Related]
9. Arg506 to Gln mutation in the factor V gene causes poor fibrinolytic response in children after venous occlusion.
Nowak-Göttl U; Binder M; Dübbers A; Kehrel B; Koch HG; Veltmann H; Vielhaber H
Thromb Haemost; 1997 Sep; 78(3):1115-8. PubMed ID: 9308763
[TBL] [Abstract][Full Text] [Related]
10. Factor V Leiden and prothrombin gene G 20210 A variant in children with ischemic stroke.
Zenz W; Bodó Z; Plotho J; Streif W; Male C; Bernert G; Rauter L; Ebetsberger G; Kaltenbrunner K; Kurnik P; Lischka A; Paky F; Ploier R; Höfler G; Mannhalter C; Muntean W
Thromb Haemost; 1998 Nov; 80(5):763-6. PubMed ID: 9843168
[TBL] [Abstract][Full Text] [Related]
11. [Arg506 --> Gln mutation of coagulation factor V (factor V Leiden) and transient cerebral ischemia at a young age in 3 members of the same family].
Moia M; La Spina I; Padalino R; Carpenedo M
Ann Ital Med Int; 1996; 11(1):17-9. PubMed ID: 8645525
[TBL] [Abstract][Full Text] [Related]
12. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
Dahlbäck B
Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447
[TBL] [Abstract][Full Text] [Related]
13. [Brain stem ischemia in a boy with resistance to C activated protein and elevated lipoprotein A].
Sameiro-Barreirinho M; Costa E; Moreira A; Barbot J; Barbot C; Santos M
Rev Neurol; 1999 Jun 1-15; 28(11):1061-4. PubMed ID: 10390775
[TBL] [Abstract][Full Text] [Related]
14. Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting.
Moor E; Silveira A; van't Hooft F; Tornvall P; Blombäck M; Wiman B; Rydén L; Hamsten A
Thromb Haemost; 1998 Aug; 80(2):220-4. PubMed ID: 9716141
[TBL] [Abstract][Full Text] [Related]
15. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
Dahlbck B
J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
[TBL] [Abstract][Full Text] [Related]
16. Factor V Leiden, prothrombin 20210G-->A and the MTHFR C677T mutations in childhood stroke.
McColl MD; Chalmers EA; Thomas A; Sproul A; Healey C; Rafferty I; McWilliam R; Eunson P
Thromb Haemost; 1999 May; 81(5):690-4. PubMed ID: 10365738
[TBL] [Abstract][Full Text] [Related]
17. Factor V Leiden mutation: an unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis.
Thorarensen O; Ryan S; Hunter J; Younkin DP
Ann Neurol; 1997 Sep; 42(3):372-5. PubMed ID: 9307261
[TBL] [Abstract][Full Text] [Related]
18. Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease.
Zöller B; He X; Dahlbäck B
Thromb Haemost; 1995 May; 73(5):743-5. PubMed ID: 7482396
[TBL] [Abstract][Full Text] [Related]
19. [Resistance to activated protein C. The most common cause of familial thrombophilia].
Larsen TB; Ravn HB; Lassen JF; Lund ED; Brandslund I
Ugeskr Laeger; 1996 Nov; 158(46):6584-8. PubMed ID: 8966822
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
